• Monday, Oct 03, 2022
  • Last Update : 10:24 am

Cancer patients' own cells used in 3D printed tumours to test treatments

  • Published at 11:17 am August 19th, 2021
Israeli researcher Lena Neufeld examines a 3D model of a malignant tumour, as part of a brain cancer research that uses patients' cells to make 3D printed models of tumours, at Tel Aviv University, Israel. The photo was taken on 17 August, 2021 Reuters

Researchers have often 3D printed tumour models to plan for surgery, but more recent innovations have focused on bioprinting, which uses live cells as a sort of ink to build up the layers

Researchers have used brain cancer patients' own cells in a form of 3D printing material to make a model of their tumour to test the efficacy of potential treatments before using them for real inside the body.

The scientists extract ‘a chunk’ of the tumour from the brain of a patient with glioblastoma–an aggressive cancer with a very poor prognosis–and use it to print a model matching their MRI scans, said Professor Ronit Satchi-Fainaro, who led the research at Tel Aviv University.

The patient's blood is then pumped through the printed tumour, made with a compound that mimics the brain, followed by a drug or therapeutic treatment.

While previous research has used such ‘bioprinting’ to simulate cancer environments, the Tel Aviv University researchers say they are the first to print a ‘viable’ tumour.

"We have about two weeks (to) test all the different therapies that we would like to evaluate (on) that specific tumour, and get back with an answer - which treatment is predicted to be the best fit," Satchi-Fainaro said.

A treatment is deemed promising if the printed tumour shrinks or if it lowers metabolic activity against control groups.

The research was published on Wednesday in the journal Science Advances.

Also Read - Lab-grown human brain develops eyes that can see, sense light

Glioblastoma is the most common form of brain cancer in adults. It spreads quickly to other parts of the brain, making it difficult to treat. Survival is around 40 per cent in the first year after diagnosis and 17 per cent in the second, according to the American Association of Neurological Surgeons.

Researchers have often 3D printed tumour models to plan for surgery, but more recent innovations have focused on bioprinting, which uses live cells as a sort of ink to build up the layers.

Ofra Benny, who leads similar research at the Hebrew University of Jerusalem, said the use of a patient's own cells to develop 3D tumour models could be "a game changer in the field of personalised medicine".

"The more physiological mimicry you create, the better prediction you get in terms of how drug treatments will work on the actual tumour in the patient's body," she said.

Facebook 50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail